Microfluidic Production of Mangiferin-Loaded Liposomes Enables Gut–Joint Axis Modulation for Early Osteoarthritis Intervention

Microfluidic nanomanufacturing provides a controllable and scalable strategy for improving the oral delivery of poorly bioavailable natural compounds. Herein, mangiferin-loaded liposomes (Lip@MG) were fabricated using an in-house-developed continuous microfluidic platform integrated with a high-efficiency micromixer and evaluated as a gut-joint axis-oriented intervention for early knee osteoarthritis (KOA). Compared with the conventional batch method, microfluidic synthesis produced Lip@MG with a more uniform spherical morphology, a clearly defined bilayer structure, and a narrower particle size distribution. By adjusting the flow-rate ratio, Lip@MG with tunable particle sizes from 207.8 to 118.6 nm, reduced polydispersity, and stable negative zeta potentials of up to approximately -35 mV was obtained. In vitro, Lip@MG exhibited favorable cytocompatibility and enhanced chondrocyte viability. Transcriptomic analysis, qRT-PCR, and western blot further indicated that Lip@MG attenuated LPS-induced inflammatory responses in chondrocytes, at least partly by suppressing NF-κB signaling and inhibiting p65 phosphorylation. In an anterior cruciate ligament transection-induced KOA mouse model, oral Lip@MG administration alleviated cartilage degeneration, increased cartilage thickness from 132 to 215 μm, reduced the OARSI score from 2.5 to 1.5, increased subchondral bone mineral density by 27%, and restored colonic barrier integrity, as reflected by a 65% reduction in the colonic histopathological score. Full-length 16S rRNA gene sequencing revealed that Lip@MG reshaped KOA-associated gut dysbiosis by partially restoring the Firmicutes/Bacteroidetes balance and enriching potentially beneficial taxa. These findings demonstrate that microfluidically manufactured Lip@MG is a promising nutritional nanocarrier for microbiota-centered early KOA intervention through coordinated regulation of intestinal homeostasis and joint degeneration.

Authors

Institutions

Publication Details

Journal
ACS Applied Materials & Interfaces
Published
2026-10-30
DOI
https://doi.org/10.1021/acsami.6c14321
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Microfluidic Production of Mangiferin-Loaded Liposomes Enables Gut–Joint Axis Modulation for Early Osteoarthritis Intervention

Bin Ran, Luxu Yin, Wenxin Li, Mian Li et al.
5 links
ACS Applied Materials & Interfaces
Osteoarthritis Treatment and Mechanisms
article

Microfluidic Production of Mangiferin-Loaded Liposomes Enables Gut–Joint Axis Modulation for Early Osteoarthritis Intervention

Bin Ran, Luxu Yin, Wenxin Li, Mian Li, Bo Liu, Jinxiang Han, Yan Zhao, Dan Liu, Bing Wang, Jingyu Li, Yiqun Ren
article en

Abstract

Microfluidic nanomanufacturing provides a controllable and scalable strategy for improving the oral delivery of poorly bioavailable natural compounds. Herein, mangiferin-loaded liposomes (Lip@MG) were fabricated using an in-house-developed continuous microfluidic platform integrated with a high-efficiency micromixer and evaluated as a gut-joint axis-oriented intervention for early knee osteoarthritis (KOA). Compared with the conventional batch method, microfluidic synthesis produced Lip@MG with a more uniform spherical morphology, a clearly defined bilayer structure, and a narrower particle size distribution. By adjusting the flow-rate ratio, Lip@MG with tunable particle sizes from 207.8 to 118.6 nm, reduced polydispersity, and stable negative zeta potentials of up to approximately -35 mV was obtained. In vitro, Lip@MG exhibited favorable cytocompatibility and enhanced chondrocyte viability. Transcriptomic analysis, qRT-PCR, and western blot further indicated that Lip@MG attenuated LPS-induced inflammatory responses in chondrocytes, at least partly by suppressing NF-κB signaling and inhibiting p65 phosphorylation. In an anterior cruciate ligament transection-induced KOA mouse model, oral Lip@MG administration alleviated cartilage degeneration, increased cartilage thickness from 132 to 215 μm, reduced the OARSI score from 2.5 to 1.5, increased subchondral bone mineral density by 27%, and restored colonic barrier integrity, as reflected by a 65% reduction in the colonic histopathological score. Full-length 16S rRNA gene sequencing revealed that Lip@MG reshaped KOA-associated gut dysbiosis by partially restoring the Firmicutes/Bacteroidetes balance and enriching potentially beneficial taxa. These findings demonstrate that microfluidically manufactured Lip@MG is a promising nutritional nanocarrier for microbiota-centered early KOA intervention through coordinated regulation of intestinal homeostasis and joint degeneration.

ACS Applied Materials & Interfaces
Shandong University (CN), Harbin Institute of Technology (CN), Heze Municipal Hospital (CN), Shandong Provincial QianFoShan Hospital (CN), Shandong First Medical University (CN)
Natural Science Foundation of Shandong Province, Taishan Scholar Project of Shandong Province
Good health and well-being
Openalex Percentile: Top 11%
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon